The unique 6 x 6 fluidics of the ProteOn XPR36 system deliver robust kinetics for up to six targets in one shot. Up to 36 different interactions can be monitored simultaneously by injecting six different analytes over six different ligands. This high-throughput feature of the ProteOn system allows for fast and accurate characterization of multiple binding interactions in parallel, reducing sample processing time and greatly speeding protocol optimization. The novel XPR™ technology confers advantages found only on the ProteOn system, such as real-time double referencing — which allows for highly stable baselines — and increased flexibility in experimental design (Bronner et al. 2006, Cohen et al. 2009, Cohavi et al. 2009). Association (ka) and dissociation (kd) kinetic constants can be easily extracted from the data by using the ProteOn Manager™ Software to fit experimental data to a number of binding models, ranging from a simple Langmuir 1:1 binding model to Langmuir binding with mass transport or heterogeneous ligand and analyte models.
Webinars addressing various aspects of Kinetic Characterization with the ProteOn XPR36 system:
ProteOn XPR36 and Lipoparticle Technology, a Powerful Combination for Screening Antibody Therapeutics Against Membrane Proteins
Presented by Sharon Willis, PhD (Integral Molecular, USA)
Download recorded webinar
Novel Liposome Immobilization Using LayerLab Technology
Presented by Torbjorn Pettersson, PhD and Magnus Branden, PhD (LayerLab, Sweden)
Download recorded webinar
Pushing ProteOn to Its Limits — From Protein-Protein Docking to Nanoparticle Interactions
Presented by Gideon Schreiber, PhD (Weizmann Institute, Israel)
Download recorded webinar
Bio-Rad is Evolving SPR — Featuring the New ProteOn Manager Software and the New His-tag Capture Sensor Chip
Presented by Ruben Luo, PhD (Bio-Rad Laboratories, USA)
Download recorded webinar
New Features of ProteOn Manager v3.0 and HTG Sensor Chip (English & Mandarin)
Presented by: Ruben Luo, PhD (Bio-Rad Laboratories)
Download recorded webinar
Knowing the thermodynamics of biomolecular interactions, in addition to the kinetics, can lead to a better understanding of the mechanisms behind binding and help improve rational drug design. SPR technology is capable of measuring the energetics of binding by both equilibrium-based and kinetics-based analyses. Typical thermodynamic binding experiments involve measuring kinetic parameters with the ProteOn system under a range of temperatures and calculating the dissociation equilibrium constant (KD) at each temperature. The enthalpy and entropy of binding can then be extracted by fitting the experimental data to the van't Hoff equation. Kinetic parameters measured at different temperatures with the ProteOn system can also be used to obtain transition state thermodynamics, which can be useful in designing higher affinity ligands. The ability of the ProteOn system to provide high-quality and high-throughput kinetic data at different temperatures enables parallel thermodynamic analysis of multiple biomolecular interactions (Bravman et al. 2006 and 2008).
Model system investigated by John Kulman (see webinar for details).
Thermodynamic data is determined.
Webinar relevant to thermodynamics of biomolecular interactions:
A Calcium-Dependent Immunocapture Strategy for Enhanced-Throughput SPR
Presented by John Kulman, PhD (Puget Sound Blood Center, USA)
Click to download recorded webinar: https://biorad.box.net/shared/j00jbuzdet
SPR technology serves as an efficient and powerful platform for the quantitation of biological samples. Protein quantitation and concentration analysis can be used for quality control of downstream processing or for detecting biomarkers in diagnostic research. Two major advantages of SPR over other labeled techniques (such as ELISA) for concentration analysis are that (1) label-free SPR eliminates the effort involved in labeling the analyte of interest and (2) using an SPR sensor chip surface with binding specificity (either by using a capture agent or immobilizing ligands to the surface) allows for the direct analysis of molecules from crude samples without prior sample purification.
Protein quantitation is achieved either by measuring the response at equilibrium (similar to ELISA but label free) or by obtaining the initial binding rate. The latter is often used due to its ease of use and rapid results. The concentration of an unknown sample is calculated by comparing the binding response under these conditions to a standard curve of binding responses for known concentrations. The parallel fluidics and reproducibility of the ProteOn system enables reliable and high-throughput concentration analysis of biological samples for both research applications and manufacturing and quality control processes.
The figures and table below illustrate the protein quantitation capabilities of the ProteOn Manager software. Data can be managed in a tabular or graphical format to display the concentration values from the standards, unknowns and control samples.
Example of protein quantitation data.
Example of standard curve.
Example of protein quantitation analysis.
Bravman T et al. (2006). Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem 358, 281–288.
This article describes the use of the ProteOn XPR36 parallel array biosensor to characterize the binding kinetics of a set of small molecule/enzyme interactions. Using the ProteOn's crisscrossing flow path system, they collected response data for six different concentrations of each analyte over six different target protein surfaces. This "one-shot" approach to kinetic analysis significantly improves throughput while generating high-quality data even for low-molecular-mass analytes. The temperature dependence (from 15 to 35 degrees C) of the kinetics for four of the inhibitor/enzyme interactions was also determined. These results illustrate the potential of this new parallel-processing biosensor to increase the speed of kinetic analysis in drug discovery and expand the applications of real-time protein interaction arrays.
Bravman T et al. (2008). The ProteOn XPR36 array system — high-throughput kinetic binding analysis of biomolecular interactions. Cell Mol Bioeng 1, 216–228.
These articles describe how the ProteOn system was used to investigate the interactions between carbonic anhydrase isozyme (CAII) and a series of known small molecule sulfonamide inhibitors. Kinetic screening results were obtained quickly using the One-shot Kinetics™ approach. The measured affinity of nine inhibitors were consistent with those determined using isothermal titration calorimetry. Temperature dependence of the kinetics was measured and van't Hoff plots were obtained to determine the thermodynamics of the CAII / carboxybenzenesulfonamide (CBS) interaction.
Bronner V et al. (2006). Mechanisms of protein-protein binding: double-mutant cycle analysis using the ProteOn XPR36 system. Bio-Rad Bulletin 5358.
This tech note employs the ProteOn system to uncover important residues for the interaction of two proteins, TEM1 beta-lactamase and its inhibitor beta-lactamase inhibitor protein (BLIP). In this study, double-mutant cycle (DMC) analysis was used along with the innovative One-shot Kinetics of the ProteOn system. The DMC analysis is an excellent tool to investigate the structure, mechanism and dynamics of protein-protein interactions. Multiple mutants of both TEM1 and BLIP were analyzed against each other to determine the contribution of residues toward the stability of the TEM1/BLIP interaction.
Cohen S et al. (2009). Applications of the ProteOn NLC sensor chip: antibody-antigen, DNA-protein, and protein-protein interactions. Bio-Rad Bulletin 5449.
This tech note describes the specificity and stability of biotinylated ligands captured to the ProteOn and NLC sensor chip. Three common biomolecular interaction models representing antigen-antibody, DNA-protein and protein-protein interactions were analyzed using the One-shot Kinetics approach. These three interaction types were analyzed in high throughout with the 6 x 6 interaction array. It also allowed for flexibility in experimental design.
Cohavi O et al. (2009). Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data. J Mol Biol 390, 503-15
This article employs the ProteOn system to analyze the interaction between ornithine decarboxylase (ODC) and a regulatory protein antizyme (Az). The binding sites of ODC on Az were mapped using high-throughput mutagenesis and computational docking. Double-mutant cycle (DMC) analysis between residues on Az and ODC was used to obtain further insights on the structure and function of the complexes.
Yousef M (2007). Advances in rapid monoclonal antibody screening. American Biotechnology Laboratory 25, 26–28.
This article describes an alternative method for the rapid screening of monoclonal antibodies using multiplexed SPR and the one-shot kinetics approach of the ProteOn™ XPR36 protein interaction array system. The ProteOn was used to screen supernatants to identify high-affinity mAb candidates against human IL-12 and hemoglobin E. Over 250 supernatants were screened in 12.5 hr in one experiment, using a single sensor chip. There was no need to purify antibodies from the supernatants prior to analysis.
